¿Fin del Alzheimer?

¿Fin del Alzheimer?

La empresa vallisoletana Biocross es una spin off —una empresa que nace como extensión de otra mediante la separación de una división subsidiaria— del CSIC (Consejo Superior de Investigaciones Científicas). ¿Su objetivo? Estudiar nuevos biomarcadores para el...
Biocross presents at Bio-Europe 2016

Biocross presents at Bio-Europe 2016

Biocross S.L., a biotechnology company focused on the development of innovative technologies for the diagnosis of Alzheimer’s disease and the identification of at-risk individuals, today announced that their Chief Executive Officer Matt Mittino will present the...
Biospain 2016 – Company Presentation

Biospain 2016 – Company Presentation

Biocross to participate in the 8th International Meeting on Biotechnology, Biospain 2016, which takes place in Bilbao (Vizcaya), September 28–30, 2016. Biospain has become the main scientific, social, commercial, and industrial meeting point of the biotechnological...